90683 CPT® code: payer coverage and prior authorization90683 appears in 4 coverage policies from Aetna, Blue Cross & Blue Shield of Rhode Island, BlueCross BlueShield of South Carolina.
| Payer | Policy | Role in policy | Reviewed | Document |
|---|---|---|---|---|
| Aetna | Palivizumab (Synagis) (0318) | listed, no stance | Aug 21, 2026 | payer document |
| Aetna | Respiratory Syncytial Virus (RSV) Vaccines for Adult and Maternal Use (1027) | covered if criteria are met | Oct 9, 2026 | payer document |
| Blue Cross & Blue Shield of Rhode Island | Immunizations Adult and Pediatric | covered if criteria are met | Jun 9, 2026 | payer document |
| BlueCross BlueShield of South Carolina | Preventive Services for Non-Grandfathered (PPACA) Plans: Immunizations (CAM 109) 90677 (effective 12/15/2021) | Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use | Both | listed, no stance | Apr 1, 2026 | payer document |
Prior authorization required or conditional in IN.
From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.